Sagayno, Louie Jean T.

HRN: 10-83-17  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2024
CEFUROXIME 750MG (VIAL)
12/19/2024
12/20/2024
IV
750MG
Q8 X 3 DOSES
S/P CLOSED REDUCTION AND PERCUTANEOUS PINNING
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: